THE 5-YEAR INCIDENCE OF BLINDNESS AFTER INTRODUCING A SCREENING-PROGRAM FOR EARLY DETECTION OF TREATABLE DIABETIC-RETINOPATHY

被引：68

作者：

AGARDH, E

AGARDH, CD

HANSSONLUNDBLAD, C

机构：

[1] Departments of Ophthalmology, University Hospital, Lund

[2] Internal Medicine, University Hospital, Lund

来源：

DIABETIC MEDICINE | 1993年 / 10卷 / 06期

关键词：

DIABETIC RETINOPATHY; BLINDNESS; PHOTOCOAGULATION; SCREENING;

D O I：

10.1111/j.1464-5491.1993.tb00120.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The incidence of moderate visual impairment and blindness due to diabetic retinopathy was studied 5 years after introducing a screening system for early detection of treatable retinopathy. Photocoagulation was performed in patients with clinically significant macular oedema, severe preproliferative, and proliferative retinopathy. Eighty-eight percent of 470 Type 1 and 88 % of 388 Type 2 diabetic patients were still available for follow-up. In the Type 1 group, the five-year incidence of blindness and moderate visual impairment were 0.5 % and 1.2 %, respectively. Corresponding figures for the Type 2 diabetic patients were 0.6 % and 1.7 %, respectively. The majority of patients with loss of vision had severe retinopathy at baseline. Among those who entered the screening programme with no or mild retinopathy, loss of vision occurred in only one of the Type 1 and four of the Type 2 diabetic patients. It is concluded that the risk for visual impairment and blindness due to diabetes can be substantially reduced by using programmes for early detection of and effective treatment of diabetic retinopathy.

引用

页码：555 / 559

页数：5

共 19 条

[1] Grey RHB, Burns-Cox CJ, Hughes A., Blind and partial sight registration in Avon, Br J Ophthalmol, 73, pp. 88-94, (1989)
[2] Sorsby A., The Incidence and Causes of Blindness in England and Wales 1963–68, (1972)
[3] Proliferative diabetic retinopathy: treatment with xenon arc photocoagulation, Br Med J, 1, pp. 739-741, (1977)
[4] Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings. DRS Report No. 8, Ophthalmology, 88, pp. 583-600, (1981)
[5] Early Photocoagulation for diabetic retinopathy. ETDRS Report No. 9, Ophthalmology, 98, pp. 766-785, (1991)
[6] Olk RJ., Modified grid argon (blue‐green) laser photocoagulation for diffuse diabetic macular edema, Ophthalmology, 93, pp. 938-950, (1986)
[7] Agardh E., Torffvit O., Agardh C-D., The prevalence of retinopathy and associated medical risk factors in type 1 (insulin‐dependent) diabetes mellitus, J Int Med, 226, pp. 47-52, (1989)
[8] Agardh E., Torffvit O., Agardh C-D., Putative risk factors associated with retinopathy in patients with diabetes diagnosed at or after 30 years of age, Diabetic Med, 6, pp. 724-727, (1989)
[9] Klein R., Klein BEK, Moss SE, Davis MD, DeMets DL., The Wisconsin epidemiologic study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years, Arch Ophthalmol, 102, pp. 520-526, (1984)
[10] Klein R., Klein BEK, Moss SE, Davis MD, DeMets DL., The Wisconsin epidemiologic study of diabetic retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years, Arch Ophthalmol, 102, pp. 527-532, (1984)

← 1 2 →